Single-agent mosunetuzumab in older or unfit patients with previously untreated DLBCL: results of a phase 1/2 trial.
- DOI
- 10.1016/j.bneo.2026.100248
- Published
- 2026-05-16
- Container
- Blood Neoplasia
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bneo.2026.100248,
title = {Single-agent mosunetuzumab in older or unfit patients with previously untreated DLBCL: results of a phase 1/2 trial.},
author = {Olszewski AJ and Avigdor A and Babu S and Levi I and Eradat H and Abadi U and Holmes H and McKinney MS and Woszczyk D and Giannopoulos K and Jurczak W and Jing J and Li D and Hamidi H and Penuel E and Janousek M and Wei MC and Batlevi C and Ead W and Sellam G and Horowitz NA.},
year = {2026},
journal = {Blood Neoplasia},
doi = {10.1016/j.bneo.2026.100248},
url = {https://doi.org/10.1016/j.bneo.2026.100248}
}RIS
TY - JOUR TI - Single-agent mosunetuzumab in older or unfit patients with previously untreated DLBCL: results of a phase 1/2 trial. AU - Olszewski AJ AU - Avigdor A AU - Babu S AU - Levi I AU - Eradat H AU - Abadi U AU - Holmes H AU - McKinney MS AU - Woszczyk D AU - Giannopoulos K AU - Jurczak W AU - Jing J AU - Li D AU - Hamidi H AU - Penuel E AU - Janousek M AU - Wei MC AU - Batlevi C AU - Ead W AU - Sellam G AU - Horowitz NA. PY - 2026 JO - Blood Neoplasia DO - 10.1016/j.bneo.2026.100248 UR - https://doi.org/10.1016/j.bneo.2026.100248 ER -
APA
AJ, O., A, A., S, B., I, L., H, E., U, A., H, H., MS, M., D, W., K, G., W, J., J, J., D, L., H, H., E, P., M, J., MC, W., C, B., W, E., G, S., & NA., H. (2026). Single-agent mosunetuzumab in older or unfit patients with previously untreated DLBCL: results of a phase 1/2 trial.. Blood Neoplasia. https://doi.org/10.1016/j.bneo.2026.100248
Source records
- europe-pmc · retrieved 2026-09-25T20:59:18.242Z